Clinical Trial Update: Study to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating Besifovir and L-carnitine in hepatitis B patients with nonalcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Besifovir (besifovir)
• L-carnitine (L-carnitine)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hepatitis B | Phase 4 | Status: UNKNOWN